Related references
Note: Only part of the references are listed.Rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab
Young Hee Yoon et al.
ACTA OPHTHALMOLOGICA (2009)
Multiple effects of bevacizumab in angiogenesis: implications for its use in age-related macular degeneration
Angela Carneiro et al.
ACTA OPHTHALMOLOGICA (2009)
Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edema
Hassan Al-Dhibi et al.
JOURNAL OF AAPOS (2009)
Monitoring Ocular Drug Therapy by Analysis of Aqueous Samples
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2009)
THE EFFECT OF UNILATERAL INTRAVITREAL BEVACIZUMAB (AVASTIN), IN THE TREATMENT OF DIFFUSE BILATERAL DIABETIC MACULAR EDEMA
Raul Velez-Montoya et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Pharmacokinetics of Bevacizumab after Topical, Subconjunctival, and Intravitreal Administration in Rabbits
Hiroyuki Nomoto et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Complications in patients after intravitreal injection of bevacizumab
Chiharu Shima et al.
ACTA OPHTHALMOLOGICA (2008)
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab
Osamu Sawada et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study
Focke Ziemssen et al.
INTERNATIONAL OPHTHALMOLOGY (2008)
Pharmacokinetics of intravitreal bevackumab (avastin)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
Acute retinal pigment epithelial tear in the untreated fellow eye following repeated bevacizumab (Avastin (TM)) injections
Stefan Mennel et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2007)
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
Robert L. Avery et al.
OPHTHALMOLOGY (2006)
Share Paper
